MHC Genotype Controls the Capacity of Ligand Density to Switch T Helper (Th)-1/Th-2 Priming in Vivo

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 3893-3901

  Schountz, Tony ^a   Kasselman, Joel P ^a   Martinson, Fred A ^a   Brown, Leasa ^a   Murray, Joseph S ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; CD86 PROTEIN, MOUSE; H2 ANTIGEN; HLA ANTIGEN CLASS 2; LEUKOCYTE ANTIGEN; LIGAND; MEMBRANE PROTEIN; PEPTIDE FRAGMENT;

A J MOUSE; ANIMAL; ANTIGEN PRESENTATION; ARTICLE; CELL DIFFERENTIATION; DOSE RESPONSE; FIBROBLAST; GENETIC TRANSFECTION; GENETICS; GENOTYPE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; MOUSE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD86; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FIBROBLASTS; GENOTYPE; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOLOGIC MEMORY; LIGANDS; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED A; PEPTIDE FRAGMENTS; TH1 CELLS; TH2 CELLS; TRANSFECTION;

EID: 0030294373     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Elson, L. H., M. H. Calvopina, W. Y. Paredes, E. N. Araujo, J. E. Bradley, R. H. Guderian, and T. B. Nutman. 1995. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. J. Infect. Dis. 171: 652.
2. Katz, J. D., C. Benoist, and D. Mathis. 1995. T helper subsets in insulin-dependent diabetes. Science 268:1185.
3. Clerici, M., F. T. Hakim, D. J. Venzon, S. Blatt, C. W. Hedrix, T. A. Wynn, and G. M. Shearer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:759.
4. + T cell subsets in response to the Plasmodium falciparum circumsporosite protein in Papua New Guinea. Parasite Immunol. 16:129.
5. Mutis, T., Y. E. Cornelisse, G. Datema, P. J. van den Elsen, T. H. M. Ottenhoff, and R. R. P. de Vries. 1994. Definition of a human suppressor T-cell epitope. Proc. Natl. Acad. Sci. USA 91:9456.
6. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227.
7. + T cell subset activation. J. Exp. Med 170:2135.
8. Soloway, P., S. Fish, H. Passmore, M. Gefter, R. Coffee, and T. Manser. 1991. Regulation of the immune response to peptide antigens: differential induction of immediate-type hypersensitivity and T cell proliferation due to changes in either peptide structure or major histocompatibility complex haplotype. J. Exp. Med. 174:847.
9. Milich, D. R., D. L. Peterson, F. Schodel, J. E. Jones, and J. L. Hughes. 1995. Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent. J. Virol. 69:2776.
10. Mustafa, M., C. Vingsbo, T. Olsson, A. Ljungdahl, B. Höjeberg, and R. Holmdahl. 1993. The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis. Eur. J. Immunol. 23:3089.
11. Harrison, L. C., M. C. Honeyman, H. J. DeAizpurua, R. S. Schmildli, P. G. Colman, B. D. Tait, and D. S. Cram. 1993. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341:1365.
12. Meyer, C. G., M. Gallin, K. D. Entmann, N. Brattig, L. Schnittger, A. Gelhaus, E. Tannisch, A. B. Begovich, H. A. Erlich, and R. D. Horstmann. 1994. HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. Proc. Natl. Acad. Sci. USA 91:7515.
13. Rosenthal, A. S., M. A. Barcinski, and J. T. Blake. 1977. Determinant selection is a macrophage-dependent immune response gene function. Nature 267:156.
14. Herber-Katz, E., D. Hansburg, and R. H. Schwartz. 1983. The Ia molecule of the antigen-presenting cell plays a critical role in immune response gene regulation of T cell activation. J. Mol. Cell. Immunol. 1:3.
15. Rudensky, A. Y, P. Preston-Hurlburt, B. K. Al-Ramadi, J. Rothbard, and C. A. Janeway, Jr. 1992. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359:429.
16. Buus, S., A. Sette, S. M. Colon, C. Miles, and H. M. Grey. 1987. The relationship between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science 235:1353.
17. Fink, P. J., and M. J. Bevan. 1978. H-2 antigens of the thymus determine lymphocyte specificity. J. Exp. Med. 148:766.
18. Sprent, J. 1978. Restricted helper function of F1→parent bone marrow chimeras controlled by K-end of H-2 complex. J. Exp. Med. 146:1838.
19. Jorgensen, J. L., U. Esser, B. Fazekas de St. Groth, P. A. Reay, and M. M. Davis. 1992. Mapping T cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355:224.
20. Murray, J. S., C. Pfeiffer, J. Madri, and K. Bottomly. 1992. MHC control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur. J. Immunol. 22:559.
21. Murray, J. S., D. Ferrandis-Edwards, C. J. Wolfe, and T. Schountz. 1994. Major histocompatibility complex regulation of T helper functions mapped to a peptide C-terminus that controls ligand density. Eur. J. Immunol. 24:2337.
22. Murray, J. S., J. P. Kasselman, and T. Schountz. 1995. High density presentation of an immunodominant minimal peptide on B cells is MHC-linked to Th1-like immunity. Cell. Immunol. 166:9.
23. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
24. + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 181:1081.
25. + T helper cell phenotype development in a T cell receptor-Ab-transgenic model. J. Exp. Med. 182:1579.
26. + T cells. J. Exp. Med. 182:1591.
27. Bretscher, P. A., G. Wei, J. N. Menon, and H. Bielefeldt-Ohmann. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539.
28. Pfeiffer, C., J. Murray, J. Madri, and K. Bottomly. 1991. Selective activation of Th1 and Th2 like cells in vivo: response to human collagen IV. Immunol. Rev. 123:65.
29. Sarzotti, M., D. S. Robbins, and P. M. Hoffman. 1996. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271:1726.
30. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
31. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
32. Ronchese, F., M. A. Brown, and R. N. Germain. 1987. Structure-function analysis of the Aβbm 12 mutation using site-directed mutagenesis and DNA-mediated gene transfer. J. Immunol. 139:629.
33. Brown, J. H., T. Jardetzky, M. Saper, B. Samraoui, P. Bjorkman, and D. C. Wiley. 1988. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 332:845.
34. Hugo, P., J. W. Kappler, J. E. McCormack, and P. Marrack. 1993. Fibroblasts can induce thymocyte positive selection in vivo. Proc. Natl. Acad. Sci. USA 90: 10335.
35. Dornmair, K., B. Rothenhäusler, and H. M. McConnell. 1989. Structural intermediates in the reactions of antigenic peptides with MHC molecules. Cold Spring Harbor Symp. Quant. Biol. 54:409.
36. Sadegh-Nasseri, S., and R. N. Germain. 1991. A role for peptide in determining MHC class II structure. Nature 353:167.
37. Jensen, P. 1992. Long-lived complexes between peptide and class II major histocompatibility complex are formed at low pH with no requirement for pH neutralization. J. Exp. Med. 176:793.
38. B. Scand. J. Immunol. 16:25.
39. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
40. Sedgwick, J. D., and P. G. Holt. 1983. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells in vitro. J. Immunol. Methods 79:195.
41. Tite, J. P., H. G. Foellmer, J. A. Madri, and C. A. Janeway, Jr. 1987. Inverse Ir gene control of the antibody and T cell proliferative responses to human basement membrane collagen. J. Immunol. 139:2892.
42. Bush, R., G. Strang, K. Howland, and I. B. Rothbard. 1990. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Int. Immunol. 2:443.
43. Schountz, T., J. P. Kasselman, S. R. Ford, and J. S. Murray. 1996. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence. Cell. Immunol. 168:193.
44. Sloan-Lancaster, J., and P. M. Allen. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1.
45. Buus, S., A. Sette, S. M. Colon, D. M. Jenis, and H. M. Grey. 1986. Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell 47:1071.
46. Lanzavecchia, A., P. A. Reid, and C. Watts. 1992. Irreversible association of peptides with class II MHC molecules in living cells. Nature 357:249.
47. Forsthuber, T., H. C. Yip, and P. V. Lehmann. 1996. Induction of TH1 and TH2 immunity in neonatal mice. Science 271:1728.
48. Parish, C. R. 1971. Immune response to chemically modified flagellin. J. Exp. Med. 134:1.
49. Stern, L., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J, L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 completed with an influenza virus peptide. Nature 368:215.
50. Matis, L., L. H. Glimcher, W. E. Paul, and R. H. Schwartz. 1993. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc. Natl. Acad. Sci. USA 80:6019.
51. Madrenas, J., R. L. Wange, J. L. Wang, N. Isakova, L. E. Samelson, and R. N. Germain. 1995. ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515.
52. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signaling: altered phospho-ζ and lack of ZAP-70 recruitment in APL-induced T cell anergy. Cell 79:913.
53. Hatada, M. H., X. Lu, E. R. Laird, J. Green, J. P. Morgenstern, M. Lou, C. S. Marr, T. B. Phillips, M. K. Ram, K. Theriault, M. J. Zoller, and J. L. Karas. 1995. Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T cell receptor. Nature 377:32.
54. Valitutti, S., S. Müller, M. Cella, E. Radovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148.
55. Janeway, C. A., Jr., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell 76:275.
56. + T cells. Science 271:1276.
57. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
58. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
59. Kuchroo, V. K., M. Prabhu Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sorbel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
60. Vyth-Dreese, F. A., T. A. M. Dellemijn, D. Majoor, and D. de Jong. 1995. Localization in situ of the co-stimulatory molecules B7.1, B7.2. CD40 and their ligands in normal human lymphoid tissue. Eur. J. Immunol. 25:3023.
61. Kaslow, R. A., M. Carrington, R. Apple, L. Park. A. Muñoz, A. J. Saah, J. J. Goedert, C. Winkler, S. J. O'Brien, C Rinaldo, R. Detels, W. Blattner, J. Phair, H. Erlich, and D. L. Mann. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med. 4:405.
62. Hasenkrug, K. J., J. M. Cory, and J. H. Stimpfling. 1987. Monoclonal antibodies defining mouse tissue antigens encoded by the H-2 region. Immunogenetics 25: 136.